Shankar Lal Rampal Dye Chem appoints Sumit Jain as Independent Director

1 min read     Updated on 19 May 2026, 06:49 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Shankar Lal Rampal Dye Chem Limited announced the results of its postal ballot conducted via remote e-voting from April 17, 2026, to May 16, 2026. Shareholders approved the appointment of Mr. Sumit Jain (DIN: 11490160) as an Independent Director for a five-year term ending April 8, 2031. The resolution received 53,511,795 votes in favour against 12 votes against, with the scrutinizer's report submitted on May 18, 2026.

powered bylight_fuzz_icon
40742165

*this image is generated using AI for illustrative purposes only.

Shankar Lal Rampal Dye Chem Limited has announced the outcome of its postal ballot process concerning the appointment of Mr. Sumit Jain as an Independent Director. The company disclosed that the resolution received approval from shareholders with the requisite majority. The voting process was conducted via remote e-voting, managed by the scrutinizer, Mr. Nitin Mehta, a Practicing Company Secretary.

Appointment Details

The special resolution sought approval for the appointment of Mr. Sumit Jain (DIN: 11490160) as an Independent Director, not liable to retire by rotation. The tenure for this position is set for five consecutive years, commencing on April 9, 2026, and concluding on April 8, 2031. The postal ballot notice was initially dispatched to shareholders on April 15, 2026.

Voting Results

The scrutinizer's report confirmed that the resolution was passed with overwhelming support. A total of 53,511,807 valid electronic votes were received during the voting period, which ran from April 17, 2026, to May 16, 2026. The breakdown of the votes indicates unanimous support from the promoter and public institution categories, with near-unanimous support from public non-institutional shareholders.

Particulars Number
Number of valid Electronic Votes received 53511807
Votes in favour of the resolution 53511795
Votes against the resolution 12

The detailed voting patterns revealed that promoters cast 47,083,070 votes in favour, while public non-institutional shareholders cast 6,404,630 votes in favour. The results were formally announced on May 18, 2026, following the submission of the scrutinizer's report.

Historical Stock Returns for Shankar Lal Rampal Dye-Chem

1 Day5 Days1 Month6 Months1 Year5 Years
-2.21%-2.44%-7.43%-36.17%-36.43%-62.28%

How might Mr. Sumit Jain's expertise and background influence Shankar Lal Rampal Dye Chem's strategic direction in the specialty chemicals sector over his five-year tenure?

Will the strengthened independent board composition improve the company's corporate governance ratings and potentially attract greater institutional investor interest?

How could the addition of a new independent director impact the board's decision-making on upcoming capital allocation, expansion plans, or M&A activity in the dye chemicals industry?

Shankar Lal Rampal Dye-Chem
View Company Insights
View All News
like16
dislike

Shankar Lal Rampal Dye-Chem Publishes Postal Ballot Advertisement for Director Appointment

2 min read     Updated on 16 Apr 2026, 01:39 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Shankar Lal Rampal Dye-Chem Limited published postal ballot advertisements in Financial Express and Business Remedies newspapers on April 16, 2026, seeking shareholder approval for Mr. Sumit Jain's appointment as Independent Director. The e-voting process runs from April 17-May 16, 2026, with results expected by May 18, 2026.

powered bylight_fuzz_icon
37276774

*this image is generated using AI for illustrative purposes only.

Shankar lal rampal dye chem Limited has published newspaper advertisements for its postal ballot notice seeking shareholder approval for the appointment of Mr. Sumit Jain as Independent Director. The company submitted the advertisement copies to stock exchanges on April 16, 2026, following the board changes announced after its meeting held on April 9, 2026.

Newspaper Advertisement Publication

The company published the postal ballot advertisement in two newspapers on April 16, 2026, as part of its regulatory compliance under SEBI (LODR) Regulations, 2015:

Publication Details: Information
Publication Date: April 16, 2026
English Newspaper: Financial Express
Hindi Newspaper: Business Remedies
Exchange Notification: April 16, 2026
Purpose: Director Appointment Approval

Postal Ballot Process Details

The postal ballot notice was originally sent on April 15, 2026, seeking shareholder approval for Mr. Sumit Jain's appointment as Independent Director:

Parameter: Details
Director Name: Mr. Sumit Jain
DIN: 11490160
Position: Independent Director
Term Duration: 5 consecutive years
Effective From: April 9, 2026
Term Until: April 8, 2031
Resolution Type: Special Resolution

E-Voting Schedule and Process

The company has announced detailed timelines for the postal ballot process with voting restricted to electronic mode only:

Particulars: Details
Cut-off Date: Friday, April 10, 2026
E-Voting Start: Friday, April 17, 2026 (09:00 AM IST)
E-Voting End: Saturday, May 16, 2026 (05:00 PM IST)
E-Voting Platform: NSDL
Results Announcement: On or before May 18, 2026
Scrutinizer: Mr. Nitin Mehta (N Mehta & Associates)

Shareholders holding shares in physical or dematerialized form as on the cut-off date of April 10, 2026, are eligible to vote electronically. The notice has been sent to members whose email IDs are registered with the company or depository participants.

Board Composition and Background

Mr. Sumit Jain's appointment follows the resignation of Mr. Murli Atal as Independent Director with effect from March 26, 2026. The appointment brings technical expertise in health sciences and business dynamics to the board:

Expertise Area: Details
Background: Pharmacy with commercial acumen
Key Skills: Pharmaceutical & Chemical Operations
Focus Areas: Strategic Business Growth, Quality Compliance
Qualification: Bachelor's Degree in Pharmaceuticals

Due to the board composition change, three key committees were reconstituted effective April 9, 2026, including the Audit Committee and Stakeholders' Relationship Committee.

Regulatory Compliance

The newspaper advertisement publication represents the company's continued compliance with regulatory requirements. The company had earlier filed a corrigendum on April 9, 2026, to correct typographical errors in the original board meeting outcome, specifically addressing committee reconstitution dates and postal ballot cut-off dates.

Historical Stock Returns for Shankar Lal Rampal Dye-Chem

1 Day5 Days1 Month6 Months1 Year5 Years
-2.21%-2.44%-7.43%-36.17%-36.43%-62.28%

How might Mr. Sumit Jain's pharmaceutical expertise influence Shankar Lal Rampal Dye Chem's strategic direction toward pharmaceutical chemicals or drug intermediates?

What impact could the recent board restructuring and committee reconstitution have on the company's governance decisions and operational efficiency?

Will the company's shift to electronic-only voting for this postal ballot signal a permanent move away from physical voting processes for future shareholder resolutions?

Shankar Lal Rampal Dye-Chem
View Company Insights
View All News
like20
dislike

More News on Shankar Lal Rampal Dye-Chem

1 Year Returns:-36.43%